It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2007.
2007 | Ahmedabad, Gujarat, India | ActiveTraxxim Biomedicines Private Limited, a active private limited company, was established on 17 September 2007 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232GJ2007PTC051746. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹4.50 M.
It upholds a compliant status. Its leadership includes Nirupama Gupta Yogeshbhai (Director), Yogesh Roshanlal Gupta (Additional Director). Past directors included Anuj Gupta, Nirupama Gupta Yogeshbhai, Manoj Gupta Kumar. It holds no open charges and ₹3.32 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at S-109, Sangath-Ii, Motera Stadium Road, Sabarmati,, Ahmedabad, Gujarat, 380027.
U24232GJ2007PTC051746
051746
17 September 2007
₹4.50 M
₹4.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Traxxim Biomedicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirupama Gupta Yogeshbhai | Director | 01 Jul 2017 | Current |
| Yogesh Roshanlal Gupta | Additional Director | 17 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jul 2014 | Past |
| Pramod Abcsdd | Director | 25 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 04 Feb 2017 | Past |
| Pramod Abcsdd | Director | 20 Oct 2022 | Past |
| Pramod Abcsdd | Director | 09 Feb 2017 | Past |
| Pramod Abcsdd | Director | 07 Jul 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Traxxim Biomedicines Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Traxxim Biomedicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹33,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2015 | Dena Bank | ₹1.95 Cr | Satisfied |
| 25 Nov 2013 | Bank Of Baroda | ₹1.37 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Traxxim Biomedicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Traxxim Biomedicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Traxxim Biomedicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Yogesh Roshanlal Gupta was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
Traxxim Biomedicines Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on Traxxim Biomedicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Ahmedabad. was documented.
The activity Nirupama Gupta Yogeshbhai was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 8 years 5 months . was completed.
The activity A charge registered on 09 Jan 2015 via Charge ID 10544913 with Dena Bank was fully satisfied on 27 Mar 2017. was completed.
The activity A charge with Dena Bank amounted to Rs. 19.50 M with Charge ID 10544913 was registered on 09 Jan 2015. was completed.
The CIN of Traxxim Biomedicines Private Limited is U24232GJ2007PTC051746.
Traxxim Biomedicines Private Limited is headquartered at S-109, Sangath-Ii, Motera Stadium Road, Sabarmati,, Ahmedabad, Gujarat, 380027.
Traxxim Biomedicines Private Limited was incorporated on 17 September 2007.
The current directors of Traxxim Biomedicines Private Limited are
The primary industry of Traxxim Biomedicines Private Limited is Trade.
Traxxim Biomedicines Private Limited is unlisted.
The authorized capital of Traxxim Biomedicines Private Limited is ₹4.50 M, and the paid-up capital is ₹4.50 M.
The compliance status of Traxxim Biomedicines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX